Biohaven Statistics
Total Valuation
Biohaven has a market cap or net worth of $2.10 billion. The enterprise value is $1.81 billion.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohaven has 102.06 million shares outstanding. The number of shares has increased by 29.20% in one year.
| Current Share Class | 102.06M |
| Shares Outstanding | 102.06M |
| Shares Change (YoY) | +29.20% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 11.55% |
| Owned by Institutions (%) | 87.19% |
| Float | 84.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 24.85 |
| PB Ratio | 8.09 |
| P/TBV Ratio | 8.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.33 |
| Quick Ratio | 1.97 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -316.82% and return on invested capital (ROIC) is -183.31%.
| Return on Equity (ROE) | -316.82% |
| Return on Assets (ROA) | -129.99% |
| Return on Invested Capital (ROIC) | -183.31% |
| Return on Capital Employed (ROCE) | -309.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.47M |
| Employee Count | 256 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Biohaven has paid $775,000 in taxes.
| Income Tax | 775,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.39% in the last 52 weeks. The beta is 4.18, so Biohaven's price volatility has been higher than the market average.
| Beta (5Y) | 4.18 |
| 52-Week Price Change | -42.39% |
| 50-Day Moving Average | 24.02 |
| 200-Day Moving Average | 37.83 |
| Relative Strength Index (RSI) | 45.14 |
| Average Volume (20 Days) | 2,184,578 |
Short Selling Information
The latest short interest is 7.81 million, so 7.65% of the outstanding shares have been sold short.
| Short Interest | 7.81M |
| Short Previous Month | 7.49M |
| Short % of Shares Out | 7.65% |
| Short % of Float | 9.22% |
| Short Ratio (days to cover) | 3.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -912.53M |
| Pretax Income | -750.36M |
| Net Income | -888.60M |
| EBITDA | -904.16M |
| EBIT | -912.53M |
| Earnings Per Share (EPS) | -$9.23 |
Full Income StatementBalance Sheet
The company has $322.75 million in cash and $30.80 million in debt, giving a net cash position of $291.95 million or $2.86 per share.
| Cash & Cash Equivalents | 322.75M |
| Total Debt | 30.80M |
| Net Cash | 291.95M |
| Net Cash Per Share | $2.86 |
| Equity (Book Value) | 259.50M |
| Book Value Per Share | 2.54 |
| Working Capital | 218.72M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |